| Functional Testing Solutions Llc | |
|
750 Prides Xing Ste 112, Newark, DE 19713-6107 | |
| (302) 562-7335 | |
| Not Available |
| Full Name | Functional Testing Solutions Llc |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist |
| Location | 750 Prides Xing Ste 112, Newark, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366069643 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Functional Testing Solutions Llc 1602 Newport Gap Pike, Wilmington, DE 19808-6208 Ph: (302) 562-7335 | Functional Testing Solutions Llc 750 Prides Xing Ste 112, Newark, DE 19713-6107 Ph: (302) 562-7335 |
News Archive
As hotter temperatures draw Arizonans to the state's high country, Department of Health Services Director Catherine Eden advised residents to take precautions against tick bites because some ticks carry germs that cause disease, including Rocky Mountain spotted fever.
On Thursday 26 March, the Liverpool School of Tropical Medicine will bring together high-level representatives from organizations like the World Health Organization and key stakeholders in the private and public sectors along with scientists and doctors.
Genzyme Corporation today reported five-year patient data from its completed Phase 2 multiple sclerosis (MS) trial. This sub-group analysis found that nearly 90 percent of alemtuzumab-treated patients were free of sustained accumulation of disability, and that patients receiving alemtuzumab also maintained improved mean disability scores and a low risk of relapse over the 60-month follow-up period.
Agfa HealthCare announced today that Monongalia General Hospital has selected the company's DX-D Retrofit with dual cesium wireless detectors to convert an existing analog X-ray room into a fully digital system.
Researchers at Mount Sinai School of Medicine have found a potential new treatment for osteonecrosis, or the death of bone tissue, in people who are treated with steroids for several common medical conditions. There are currently no treatment options for people with this debilitating disease. The research is published in the April 27 issue of Proceedings of the National Academy of Sciences.
› Verified 8 days ago
Mara L Sharp, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Tyre Ave, Newark, DE 19711 Phone: 302-454-2047 Fax: 302-454-5442 | |
Elizabeth B Jones, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Tyre Ave, Newark, DE 19711 Phone: 302-454-2047 Fax: 302-454-5443 | |
Stephanie Vantrease, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 620 E Chestnut Hill Rd, Newark, DE 19713 Phone: 302-985-3281 | |
Ellen Erin Latronico, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Tyre Ave, Newark, DE 19711 Phone: 302-454-2047 Fax: 302-454-5442 | |
Samantha Fulton, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 99 Middleboro Rd, Newark, DE 19711 Phone: 302-992-5574 | |
Warna Warren, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Tyre Ave, Newark, DE 19711 Phone: 302-454-2047 | |
Mrs. Gina Castiglione-jeandell, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 212 Arrowwood Dr, Newark, DE 19713 Phone: 302-379-4329 |